Creotech Instruments Statistics

Total Valuation

Creotech Instruments has a market cap or net worth of PLN 358.09 million. The enterprise value is 322.42 million.

Market Cap	358.09M
Enterprise Value	322.42M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Creotech Instruments has 2.38 million shares outstanding. The number of shares has increased by 27.23% in one year.

Current Share Class	n/a
Shares Outstanding	2.38M
Shares Change (YoY)	+27.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.84%
Owned by Institutions (%)	21.87%
Float	1.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.66
PB Ratio	4.27
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.88
EV / Sales	7.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.72

Financial Position

The company has a current ratio of 4.12, with a Debt / Equity ratio of 0.29.

Current Ratio	4.12
Quick Ratio	3.56
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	-1.10
Interest Coverage	-5.95

Financial Efficiency

Return on equity (ROE) is -25.62% and return on invested capital (ROIC) is -13.88%.

Return on Equity (ROE)	-25.62%
Return on Assets (ROA)	-8.81%
Return on Capital (ROIC)	-13.88%
Revenue Per Employee	180,498
Profits Per Employee	-70,838
Employee Count	229
Asset Turnover	0.30
Inventory Turnover	0.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.07% in the last 52 weeks. The beta is -0.10, so Creotech Instruments's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-27.07%
50-Day Moving Average	152.74
200-Day Moving Average	181.62
Relative Strength Index (RSI)	48.87
Average Volume (20 Days)	2,174

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Creotech Instruments had revenue of PLN 41.33 million and -16.22 million in losses. Loss per share was -6.82.

Revenue	41.33M
Gross Profit	32.25M
Operating Income	-19.57M
Pretax Income	-19.63M
Net Income	-16.22M
EBITDA	-16.57M
EBIT	-19.57M
Loss Per Share	-6.82

Full Income Statement

Balance Sheet

The company has 59.77 million in cash and 24.10 million in debt, giving a net cash position of 35.67 million or 14.99 per share.

Cash & Cash Equivalents	59.77M
Total Debt	24.10M
Net Cash	35.67M
Net Cash Per Share	14.99
Equity (Book Value)	83.82M
Book Value Per Share	35.23
Working Capital	59.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.42 million and capital expenditures -25.32 million, giving a free cash flow of -21.90 million.

Operating Cash Flow	3.42M
Capital Expenditures	-25.32M
Free Cash Flow	-21.90M
FCF Per Share	-9.21

Full Cash Flow Statement

Margins

Gross margin is 78.01%, with operating and profit margins of -47.34% and -39.25%.

Gross Margin	78.01%
Operating Margin	-47.34%
Pretax Margin	-47.50%
Profit Margin	-39.25%
EBITDA Margin	-40.08%
EBIT Margin	-47.34%
FCF Margin	-52.99%

Dividends & Yields

Creotech Instruments does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.23%
Shareholder Yield	-27.23%
Earnings Yield	-4.53%
FCF Yield	-6.12%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Creotech Instruments has an Altman Z-Score of 3.35.

Altman Z-Score	3.35
Piotroski F-Score	n/a